Andrew E. Ajani

Andrew E. Ajani

Auto-generated profile, based on publicly available information

Andrew E. Ajani

Royal Melbourne Hospital, Australia

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 October 2006 in Medical Journal of Australia
Verified
Journal Article
Closed access
PDF file
BYBryan P Yan
Bryan P Yan
AAAndrew E Ajani
Andrew E Ajani
SDStephen J Duffy
Stephen J Duffy
GNGishel New
Gishel New
MHMark Horrigan
Mark Horrigan
DCDavid J Clark
David J Clark
Objective: We aimed to assess the pattern of use of drug‐eluting stents (DESs) in patients undergoing percutaneous coronary interventions (PCIs) in Victorian public hospitals. Design, setting and pat...

4 February 2021 in European Heart Journal - Quality of Care and Clinical Outcomes
Verified
Journal Article
Closed access
PDF file
MDMisha Dagan
Misha Dagan
DDDiem T Dinh
Diem T Dinh
JSJulia Stehli
Julia Stehli
CTChristianne Tan
Christianne Tan
ABAngela Brennan
Angela Brennan
SDStephen J Duffy
Stephen J Duffy
We sought to investigate if sex disparity exists for secondary prevention pharmacotherapy following acute coronary syndrome (ACS) and impact on long-term clinical outcomes. We analysed data on medical management 30-day post-percutaneous coronary intervention (PCI) for ACS in 20 976 patients within the multicentre Melbourne Interventional Group registry (2005–2017). Optimal medical therapy (OMT) was defined as five guideline-recommended medications, near-optimal medical therapy (NMT) as four medications, sub-optimal medical therapy (SMT) as ≤3 medications. Overall, 65% of patients received OMT, 27% NMT and 8% SMT. Mean age was 64 ± 12 years; 24% (4931) were female. Women were older (68 ± 12 vs. 62 ± 12 years) and had more comorbidities. Women were less likely to receive OMT (61% vs. 66%) and more likely to receive SMT (10% vs. 8%) compared to men, P < 0.001. On long-term follow-up (median 5 years, interquartile range 2–8 years), women had higher unadjusted mortality (20% vs. 13%, P < 0.001). However, after adjusting for medical therapy and baseline risk, women had lower long-term mortality [hazard ratio (HR) 0.88, 95% confidence interval (CI) 0.79–0.98; P = 0.02]. NMT (HR 1.17, 95% CI 1.05–1.31; P = 0.004) and SMT (HR 1.79, 95% CI 1.55–2.07; P < 0.001) were found to be independent predictors of long-term mortality. Women are less likely to be prescribed optimal secondary prevention medications following PCI for ACS. Lower adjusted long-term mortality amongst women suggests that as well as baseline differences between gender, optimization of secondary prevention medical therapy amongst women can lead to improved outcomes. This highlights the need to focus on minimizing the gap in secondary prevention pharmacotherapy between sexes following ACS.

8 July 2015 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
LCLachlan T. Couper
Lachlan T. Couper
PLPhilippa Loane
Philippa Loane
NANick Andrianopoulos
Nick Andrianopoulos
ABAngela Brennan
Angela Brennan
SNShane Nanayakkara
Shane Nanayakkara
OIon behalf of the Melbourne Interventional Group (MIG) Investigators
on behalf of the Melbourne Interventional Group (MIG) Investigators

31 January 2022 in Cardiovascular Revascularization Medicine
Verified
Journal Article
Closed access
GHGarry W. Hamilton
Garry W. Hamilton
JYJulian Yeoh
Julian Yeoh
DDDiem Dinh
Diem Dinh
ABAngela Brennan
Angela Brennan
MYMatias B. Yudi
Matias B. Yudi
AAAndrew E. Ajani
Andrew E. Ajani

1 January 2010 in Heart, Lung and Circulation
Verified
Journal Article
Closed access
PDF file
ABA. Brennan
A. Brennan
DDD. Dinh
D. Dinh
CCC. Costolloe
C. Costolloe
NJN. Johnston
N. Johnston
JMJohn McNeil
John McNeil
CRC. Reid
C. Reid

1 January 2010 in Heart, Lung and Circulation
Verified
Journal Article
Closed access
PDF file
WCWilliam Chan
William Chan
NAN. Andrianopoulos
N. Andrianopoulos
DCD. Clark
D. Clark
AAA. Ajani
A. Ajani
ABA. Brennan
A. Brennan
SDS. Duffy
S. Duffy